Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis

Table 5 League table with OR estimates of each pair of interventions accompanied by 95%CI according to the prevention of moderate-to-severe PEP (significant difference when OR < 1 and CI < 1)

Indomethacin+GTN	Diclofenac 100 mg	Indomethacin	Diclofenac 50 mg	tra-GTN	Naproxen	Placebo
0.71 (0.17, 2.96)
0.44 (0.17, 1.16)	0.61 (0.20, 1.87)
0.47 (0.05, 4.40)	0.66 (0.07, 6.62)	1.07 (0.13, 8.55)
0.28 (0.09, 0.85)	0.39 (0.11, 1.36)	0.63 (0.30, 1.34)	0.59 (0.07, 4.95)
0.24 (0.07, 0.82)	0.34 (0.11, 1.02)	0.55 (0.24, 1.27)	0.52 (0.06, 4.65)	0.88 (0.32, 2.46)
0.19 (0.08, 0.48)	0.27 (0.09, 0.79)	0.43 (0.28, 0.66)	0.41 (0.05, 3.11)	0.69 (0.37, 1.28)	0.78 (0.35, 1.77)

GTN: Glyceryl trinitrate; sub-GTN: Sublingual glyceryl trinitrate; tra-GTN: Transdermal glyceryl trinitrate.